diglycyl-glycine,
GGG peptide,
Gly-Gly-Gly,
glycyl-glycyl-glycine,
triglycine,
triglycine sulfate,
556-33-2,
Glycylglycylglycine,
Triglycine,
H-Gly-Gly-Gly-OH,
Glycyl-glycyl-glycine,
Diglycylglycine,
Gly-Gly-Gly,
N-(N-Glycylglycyl)glycine,
GlyGlyGly,
2-(2-(2-Aminoacetamido)acetamido)acetic acid,
Glycine, glycylglycyl-,
UNII-CVK73ZDQ8B,
MFCD00036223,
CVK73ZDQ8B,
CHEMBL54278,
Glycine, N-(N-glycylglycyl)-,
CHEBI:63961,
XKUKSGPZAADMRA-UHFFFAOYSA-N,
Glycine, N-(N-glycylglycyl)- (8CI)(9CI),
[2-(2-Amino-acetylamino)-acetylamino]-acetic acid,
2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetic acid,
2-[2-(2-aminoacetamido)acetamido]acetic acid,
Glycylpeptide,
gly-l-gly-l-gly,
Triglycine (van),
NSC46707,
EINECS 209-122-0,
Gly-Gly-Gly-OH,
NSC 46707,
AC1L1WQV,
AC1Q5OLJ,
Maybridge1_006812,
(Gly)3,
ACMC-209lo4,
AC1Q53LB,
Glycylglycylglycine, 98+%,
SCHEMBL98565,
N-(N-GLYCYLGLYCYL)-Glycine,
CTK1H1133,
HMS560N14,
DTXSID80204140,
ZINC1678871,
ANW-32354,
BDBM50188484,
CH-431,
NSC-46707,
SBB071512,
AKOS005207234,
DS-7430,
MCULE-8930278374,
RL04099,
RTR-019606,
AK161962,
AN-45900,
I756,
SC-15976,
SY025319,
TR-019606,
FT-0690006,
G0126,
Gly-Gly-Gly, BioUltra, >=99.0% (NT),
ST24039135,
2-[[2-(glycylamino)acetyl]amino]acetic acid,
MFCD00036223 (95%),
(([(Aminoacetyl)amino]acetyl)amino)acetic acid,
K-9925,
(([(Aminoacetyl)amino]acetyl)amino)acetic acid #,
2-[2-(2-aminoacetylamino)acetylamino]acetic acid,
556G332,
I04-1654,
Triglycine, United States Pharmacopeia (USP) Reference Standard,
C6H11N3O4,
CID11161,
C6-H11-N3-O4,
ACN-037006,
Glycylglycylglycine, 99% - 25G 25g,
GGG,